SCHEMBL23701497

SCHEMBL23701497

CC(C)C1c2nc(Cl)ccc2C(C)N1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
LMNA P02545 1/20 0.36
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
KCNK3 O14649 3/20 0.33
KCNK9 Q9NPC2 3/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
STS P08842 1/20 0.32
POLB P06746 1/20 0.32
ABCB1 P08183 1/20 0.32
CHRM2 P08172 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16968605 0.80 TRPA1 (0.34) KCNK3KCNK9CACNA1GCACNA1HCACNA1I
SCHEMBL30139764 0.80 TRPA1 (0.34) KCNK3KCNK9CACNA1GCACNA1HCACNA1I
SCHEMBL16968545 0.74 RORC (0.34)
SCHEMBL24723975 0.72 CHRM2 (0.39) NPC1ALDH1A1MAPTMAPK1HTT
SCHEMBL21591623 0.71 KMT2A (0.38) KMT2ALMNAHSP90AA1HSP90AB1ALDH1A1
SCHEMBL21594157 0.71 KMT2A (0.38) KMT2ALMNAHSP90AA1HSP90AB1ALDH1A1
SCHEMBL30496694 0.71 KMT2A (0.38) KMT2ALMNAHSP90AA1HSP90AB1ALDH1A1
SCHEMBL21594156 0.71 KMT2A (0.38) KMT2ALMNAHSP90AA1HSP90AB1ALDH1A1
SCHEMBL29757593 0.71 KMT2A (0.38) KMT2ALMNAHSP90AA1HSP90AB1ALDH1A1
SCHEMBL29757592 0.71 KMT2A (0.38) KMT2ALMNAHSP90AA1HSP90AB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535614-B2 Dihydropyrrolopyridine inhibitors of ROR-gamma VITAE PHARMACEUTICALS, LLC (US) 2022-12-27 US disclosed
US-20210238174-A1 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA VITAE PHARMACEUTICALS, LLC 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238174-A1 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA RORC, RORB, RORA KMT2A 3277/4885LMNA 4465/4885HSP90AA1 1940/4885
US-11535614-B2 Dihydropyrrolopyridine inhibitors of ROR-gamma RORC, RORB, RORA KMT2A 3277/4885LMNA 4465/4885HSP90AA1 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.